Suchergebnisse - "Di Bartolomeo, Maria"

PubPharm (218)

1

International consensus on the management of metastatic gastric cancer : step by step in the foggy landscape : Bertinoro Workshop, November 2022

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2024

von Morgagni, P. | Bencivenga, M. | Carneiro, F. | +35

2

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence : PURITY study

enthalten in: BMC cancer | 2024

von Niger, M. | Nichetti, F. | Fornaro, L. | +34

3

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study

enthalten in: BMC cancer | 2024

von Niger, M. | Nichetti, F. | Fornaro, L. | +34

4

Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study) : an international, randomized, placebo-controlled, phase 3 trial

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2024

von Kang, Y. | Ryu, M. | Di Bartolomeo, M. | +15

5

Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial

enthalten in: Gastric Cancer | 2024

von Kang, Y. | Ryu, M. | Di Bartolomeo, M. | +15

6

NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer : A Systematic Review and Meta-Analysis

enthalten in: JAMA network open | 2024

von Nichetti, F. | Rota, S. | Ambrosini, P. | +13

7

Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin

enthalten in: Clinical colorectal cancer | 2023

von Ghelardi, F. | Raimondi, A. | Morano, F. | +18

8

Anti-tumor activity of all-trans retinoic acid in gastric-cancer : gene-networks and molecular mechanisms

enthalten in: Journal of experimental & clinical cancer research : CR | 2023

von Guarrera, L. | Kurosaki, M. | Garattini, S. | +13

9

Anti-tumor activity of all-trans retinoic acid in gastric-cancer: gene-networks and molecular mechanisms

enthalten in: Journal of experimental & clinical cancer research | 2023

von Guarrera, L. | Kurosaki, M. | Garattini, S. | +13

10

Management and pharmacotherapy of pediatric colorectal carcinoma : a review

enthalten in: Expert opinion on pharmacotherapy | 2023

von Bergamaschi, L. | Chiaravalli, S. | Signoroni, S. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]